Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • For Drug Discovery Research, Laboratory Automation Needs to Be Flexible

    Jul 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | Scientists who want to implement automation in their laboratories should choose an infrastructure that can provide long-term flexibility for their teams. Increasing productivity with automation is essential to make that vision possible, and flexibility is critical for researchers to change workflows and take on new priorities quickly.
    Full story
  • Drug Repurposing Strategy Without An ‘Answer Book’

    Jul 7, 2022, 01:00 AM by User Not Found
    Bio-IT World | Scientists working in the information biology lab at Hokkaido University in Japan have come up with a drug repurposing strategy combining machine learning, unsupervised clustering of gene expression, and two-stage prediction.
    Full story
  • CloudLIMS Exhibits its Secure Medical and Healthcare LIMS @ 2022 AACC, Chicago

    Jul 6, 2022, 09:23 AM by
    CloudLIMS is exhibiting @2022 AACC Annual Scientific Meeting & Clinical Lab Expo and showcasing its Medical & Healthcare LIMS at Booth 464 from July 26 - 28 in Chicago.
    Full story
  • WHO calls for new innovations to tackle antimicrobial resistance crisis

    Jul 6, 2022, 09:21 AM by
    With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.
    Full story
  • DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

    Jul 5, 2022, 09:43 AM by
    DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
    Full story
  • CD Formulation Enlarges Particulate Matter Testing Capability

    Jul 5, 2022, 09:42 AM by
    Full story
  • A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer

    Jul 5, 2022, 09:40 AM by
    Full story
  • 3D Bioprinting Market Owing To Growth Within Biotechnology Sector from 2019 to 2028

    Jul 5, 2022, 09:37 AM by
    The global 3D bioprinting market is segmented based on technology, material, application and geography. Based on technology, the market is categorized into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting and microextrusion 3D bioprinting.
    Full story
  • BOC Sciences Highlighted Carbohydrates Harvest Admiring Fans at CPhI North America 2022

    Jul 5, 2022, 09:36 AM by
    Full story
  • BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D

    Jul 5, 2022, 09:35 AM by
    Full story
  • BOC Sciences Commitment at BIO 2022: From Concept to GMP Production

    Jul 5, 2022, 09:34 AM by
    Full story
  • IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies

    Jul 5, 2022, 09:33 AM by
    Full story
  • Millimeter-Sized Feats Of Engineering Could Enable Smart Drug Delivery

    Jul 5, 2022, 01:00 AM by User Not Found
    Bio-IT World | At Stanford University, precisely targeted drug delivery is in view using wireless micromachines that can navigate the rugged terrain of the human body, including the slippery surface of organs and vessels where blood flow may be impeded by hypertension and arterial plaques. The all-in-one amphibious robots’ locomotion is controlled by the strength and orientation of a three-dimensional magnetic field.
    Full story
  • CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service

    Jul 1, 2022, 09:13 AM by
    Full story
  • Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues

    Jul 1, 2022, 09:11 AM by
    BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.
    Full story
  • NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

    Jun 30, 2022, 09:18 AM by
    Full story
  • MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease

    Jun 30, 2022, 09:17 AM by
    MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.
    Full story
  • Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies

    Jun 30, 2022, 09:17 AM by
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138 (current)
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy